Article
Clinical significance of p53 protein expression and TP53 variation status in colorectal cancer.
BMC cancer - 31 Aug 2022
Kim Kyoung Min, Ahn Ae-Ri, Park Ho Sung, Jang Kyu Yun, Moon Woo Sung, Kang Myoung Jae, Ha Gi Won, Lee Min Ro, Chung Myoung Ja
Abstract excerpt
In human colorectal cancer (CRC), TP53 is one of the most important driver genes. Immunohistochemistry (IHC) has been used most often to assess the variational status of TP53. Recently, next-generation sequencing (NGS) of the TP53 gene has increased. However, to our knowledge, a comparison between TP53 status evaluated by IHC and NGS has not been studied. Therefore, the primary aim of this study was to compare...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
